One 70-year-old admitted to Jackson Memorial Hospital this year sparked an ethics debate when he arrived to the ER near death with the words “do not resuscitate” tattooed on his chest.

Biomedical engineers at Duke University have created a fully functioning heart muscle from pluripotent stem cells that is large enough to patch over damaged areas in human heart attack patients.

Heart failure-related hospitalizations and in-hospital mortalities have decreased significantly since the turn of the millennium, the American Heart Association has reported, despite a general increase in the burden of heart failure (HF) comorbidities.

Numbers of methamphetamine-linked heart failures have been on the rise for more than a decade, especially in U.S. veterans, according to a study presented at this year’s American Heart Association Scientific Sessions.

The number of new people diagnosed with heart failure each year in the United Kingdom is now similar to that of the most four common types of cancer combined, according to the most comprehensive review of heart failure statistics in the U.K. to date, published online Nov. 21 in The Lancet.

While 71 percent of heart patients are prescribed statins after hospitalization for heart disease, cerebrovascular disease and peripheral artery disease, just 37.4 percent retain that medication regimen a year later, researchers in Salt Lake City reported this week.

Heart failure patients might be at a disadvantage when it comes to the end of their lives as clinicians struggle to communicate outcomes and options to them, the New York Times reports.

Patients who suffer brain damage after cardiac arrest could benefit from magnetic resonance (MR) imaging following their stabilization—a measure that has been shown to predict clinical outcomes through mapping brain activity, according to new research published in the American journal Radiology.